Search

A national network of 22 nanotechnology centres across the UK was formally launched last week with £50 million in government funding.

Big pharma is hungry, and is paying biotechs breathtaking prices to fill its pipelines. This made for a heady atmosphere at BioEurope in Düsseldorf this week.

Traditional innovation has been about creating something new that an individual can pay for. That’s no longer enough, says Mats Williander.

QinetiQ is leading a new consortium from industry, academia and the "UK defence supply chain" for MEMs Applications for Defence.

This time it is a major drugs company that is setting up its fume cupboards in China.

Do you qualify for R&D Tax Credits? The Treasury offers advice for companies that spend on R&D in the UK.

Seven universities in Texas are to get $1.4 million from the US Department of Defense.

As Intel announced it was closing its research laboratory, Cambridge University announced that a US philanthropist is to fund the formation of another. Rather than disruptive computing technologies, the new institute will probe the beginning of the cosmos.

In my August 16 blog, I discussed the European challenge to Google Library project. I was sceptical about the chances of its success. Recent declarations of the French National Library director, Jean-Noel Jeanneney, the main promoter of the project, only reinforce my scepticism. According to Mr. Jeanneney, the project will be most probably called Europeana, to reflect its Greek-Latin lineage.

On October 22, Japan’s Supreme Court struck a blow for employees of major corporations, who make valuable inventions.

Intel is closing its only research lab outside the US as part of a global restructuring plan. The Cambridge lab will shut next month.

The UK’s Technology Strategy Board is to become independent of government, taking over the programme currently run from within the Department of Trade and Industry.

The Swedish Research Council has published ithe country's first long-term vision for research infrastructures, with a perspective of ten to twenty years.

For the first time biotechnology has overtaken software as the US venture capitalists’ darling, according to the quarterly MoneyTree Report published by PricewaterhouseCoopers last week.

Cambridge Enterprise’s new director vows flexibility as she enforces a controversial new campus policy on intellectual property.